ERA 2023 Insights
V

ERA 2023 Insights: Serendipity of SGLT2 Inhibition in Diabetes and Non Diabetes CKD

By ERA 2023 Insights FEATURING Vjollca Godanci Kelmendi
By ERA 2023 Insights FEATURING Vjollca Godanci Kelmendi
216 views
September 7, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Related Content

AUTOPLAY
06:38
Allan Jaffe

What Does Elevated Troponin Mean in COVID-19?

64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
11:37
ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo
37:21
University of Colorado Department of Medicine

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

Feat. R. Johnson
17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

27:24
Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan
57:35
PKD Foundation

Basics of PKD

Feat. C. Gordon
21:19
Patricia Kao

Cardio-Renal Syndrome Management: What Are the Key Factors That Impa…

26:49
Diana Isaacs

Tirzepatide Updates

19:26
Krista Varady

ADA 2022 Flipping the Metabolic Switch: Intermittent Fasting as a We…

05:08
Susan Brian

The Differences Between the Products of GLP1's and GLP/GIPs

14:19
UChicago Medicine

S-QUAD Therapy and Beyond: HFpEF in 2024

Feat. M. Belkin
06:31
Susan Brian

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

18:49
INOVA

Home Ultrasound: Revolutionaizing Antenatal Management

Feat. A. Wiznitzer
10:14
TCOYD

Automated Insulin Delivery Systems: The Omnipod 5

Feat. S. Edelman, J. Pettus
19:30
ACC 2022 Conference Coverage

Hot Topics in Heart Failure ACC.22

Feat. N. Ibrahim